Advantages

Characteristics

Immunogenicity

•  Induction of T and B cell-specific antigen

Safety

•  Inability to revert to virulent forms

•  The efficacy does not depends on toxic treatments

•  No observed significant adverse effects in clinical trials so far

Construction

•  Modifications in the transgene construct and vaccine can be made in short time

•  Optimization of plasmids and transcript is possible

Stability

•  Increased thermal stability―Long life time

Mobility

•  Easy storage and transport―No need for constant refrigeration

Time manufacturing

•  Rapid production and formulation

•  Reproducible in large-scale production